Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.610
+0.0250.55%
Volume:6.31M
Turnover:28.99M
Market Cap:28.96B
PE:7.17
High:4.615
Open:4.615
Low:4.555
Close:4.585
52wk High:6.194
52wk Low:4.116
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:0.66
T/O Rate:0.10%
Dividend:0.24
Dividend Rate:5.20%
EPS(LYR):0.643
ROE:8.32%
ROA:2.64%
PB:0.47
PE(LYR):7.17
PS:0.09

Loading ...

China Resources Pharma’s Subsidiary CR Double-Crane Posts RMB 8.07 Billion 9M 2026 Revenue; Net Profit Slips 6.5%

Bulletin Express
·
Yesterday

China Resources Pharma's China Resources Double-Crane reports 13.07 billion yuan net profit for first three quarters, down 6.51% year-on-year

Stock News
·
Yesterday

China Resources Pharmaceutical Group - China Resources Double-Crane Pharmaceutical Unaudited 9-Month Revenue of RMB 8.07 Bln, Net Profit RMB 1.31 Bln

THOMSON REUTERS
·
Yesterday

China Resources Pharma Unit Raises 800 Million Yuan Via Bonds Issue

MT Newswires Live
·
Oct 23

China Resources Pharma (03320): China Resources Sanjiu Reports 9-Month Net Profit of About RMB 2.601 Billion, Down 10.28% Year-on-Year

Stock News
·
Oct 23

CHINARES PHARMA Subsidiary Dong-E-E-Jiao Delivers RMB4.94 Billion Revenue and 4% Profit Growth in First Nine Months of 2026

Bulletin Express
·
Oct 23

KPC Pharmaceuticals Swings to RMB 0.36 Billion Loss as Nine-Month Revenue Falls 42.7%

Bulletin Express
·
Oct 23

China Resources Pharmaceutical Group - Dong-E-E-Jiao Reports Unaudited Net Profit of RMB 1.33 Bln for Nine Months Ended Sept 30, 2026

THOMSON REUTERS
·
Oct 23

China Resources Pharmaceutical Group - Dong-E-E-Jiao Reports Unaudited Revenue of RMB 4.94 Bln for Nine Months Ended Sept 30, 2026

THOMSON REUTERS
·
Oct 23

China Resources Pharmaceutical Subsidiary Tasly Pharmaceutical’s Nine-Month Net Profit Rises to RMB 1.09 Billion

Reuters
·
Oct 23

China Resources Pharmaceutical Group - Tasly Pharmaceutical 9M Revenue RMB 6.07 Bln

THOMSON REUTERS
·
Oct 23

China Resources Pharmaceutical Group Ltd - 9M Net Profit for Tasly Pharmaceutical Rmb1.09 Bln

THOMSON REUTERS
·
Oct 23

China Resources Pharmaceutical's Subsidiary Completes Issuance of RMB 800 Million Medium-Term Notes

Stock News
·
Oct 23

China Resources Pharmaceutical Completes RMB 800 Million Medium-Term Note Issuance

Reuters
·
Oct 23

China Resources Pharma Unit Raises 900 Billion Yuan Via Bonds Issue

MT Newswires Live
·
Oct 19

China Resources Pharmaceutical Subsidiary Completes Issuance of RMB900 Million Corporate Bonds

Stock News
·
Oct 16

CHINARES PHARMA Raises RMB0.90 Billion via Second-Tranche 2026 Bond, Fixed Coupon at 1.48%

Bulletin Express
·
Oct 16

CHINARES PHARMA 1H26 Results: Revenue Rises 2.0 % to RMB134.46 B; Attributable Profit Up 5.3 %

Bulletin Express
·
Sep 24

China Resources Pharma Unit's Bond Program Registration Accepted in China

MT Newswires Live
·
Sep 01

China Resources Pharma Unit KPC Wins Registration to Issue RMB 1 Billion in Medium-Term Notes

Reuters
·
Sep 01